Clinical Trial Update: A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of avelumab and axitinib in unresectable or metastatic gastrointestinal stromal tumors after failure of standard therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• Avelumab (avelumab)
• Axitinib (Axitinib)

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: COMPLETED